6-Aminocaproic acid-d6 is used in the study of hemorrhagic disorders as an effective and orally active inhibitor of plasmin and plasminogen; it functions as a potent antifibrinolytic agent by competitively binding to lysine residues on plasminogen, thereby preventing clot dissolution, inhibiting plasmin formation, and reducing fibrinolysis.